RK Capital Management LLC FL Acquires New Position in KindlyMD, Inc. $NAKA

RK Capital Management LLC FL purchased a new stake in shares of KindlyMD, Inc. (NASDAQ:NAKA) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 9,585,080 shares of the company’s stock, valued at approximately $239,052,000. KindlyMD accounts for 1.8% of RK Capital Management LLC FL’s holdings, making the stock its largest position. RK Capital Management LLC FL owned about 159.17% of KindlyMD at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Osaic Holdings Inc. bought a new position in shares of KindlyMD during the second quarter valued at approximately $215,000. Vontobel Holding Ltd. bought a new position in KindlyMD in the 3rd quarter worth about $335,000. Dynamic Technology Lab Private Ltd bought a new position in shares of KindlyMD in the third quarter worth approximately $369,000. Geode Capital Management LLC increased its holdings in shares of KindlyMD by 76.2% in the 2nd quarter. Geode Capital Management LLC now owns 19,394 shares of the company’s stock worth $484,000 after purchasing an additional 8,386 shares in the last quarter. Finally, CI Investments Inc. bought a new stake in KindlyMD in the 3rd quarter worth about $995,000.

KindlyMD Price Performance

Shares of NAKA stock opened at $0.26 on Tuesday. The company has a market capitalization of $113.48 million, a P/E ratio of -0.23 and a beta of 31.40. KindlyMD, Inc. has a one year low of $0.23 and a one year high of $34.77. The company’s 50-day simple moving average is $0.34 and its two-hundred day simple moving average is $1.17.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the stock. B. Riley Financial decreased their target price on shares of KindlyMD from $1.00 to $0.50 and set a “buy” rating for the company in a research note on Monday, February 23rd. Weiss Ratings restated a “sell (e+)” rating on shares of KindlyMD in a research note on Monday, December 29th. Two investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $4.25.

KindlyMD Company Profile

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.